| 1F: 5′-GATAGGTTGTATATGTTGGTG-3′ |
Minus-RT primers: 180 bp |
| 1R: 5′-CTAAGATCAGTGCCACAA-3′ |
|
| 2F: 5′-CAAACCGGACCTCACAGCAG-3′ (ex4) |
GFAP: α,β,γ: 789 bp; ζ: 1073 bp; Δ135: 654 bp; Δ164: 625 bp; Δex6: 568 bp; Δex7: 745 bp; X4: 909 bp |
| 2R: 5′-CCGATGGAGCCTAGAGCAGCAA-3′ (3′-UTR ex9) |
|
| 3F: 5′-GGCTGCGGCTAGACCAACTCACTGC-3′ (ex1) |
GFAP: α,β: 919 bp |
| 3R: 5′-TCCTTGTGCTCCTGCTTGGA-3′ (ex9) |
|
| 4F: 5′-CCTTCACTCCTCCTGTCATTCCA-3′ (5′-UTR ex2a) |
GFAP: γ: 1121 bp |
| 4R: 5′-CCGATGGAGCCTAGAGCAGCAA-3′ (3′-UTR ex9) |
|
| 5F: 5′-GCAGTGAGTGTATGTTGGTGAAAGTG-3′ (5′-UTR ex2a) |
GFAP: γ: 344 bp |
| 5R: 5′-GACGGGCTAAGGTGGCTTCA-3′ (ex3) |
|
| 6F: 5′-GGCTGGAGGAGGAGGGACAGAA-3′ (ex6) |
GFAP: δ/ɛ: 367 bp; κ: 739 bp |
| 6R: 5′-GGGCCTGGTGAGGCTTGCT-3′ (3′-UTR ex7a/7b) |
|
| 7F: 5′-GCATCGCCCACCAGCACCT-3′ (promoter) |
GFAP: gDNA: 812 bp (ex 1) |
| 7R: 5′-GGGTAAACAGAGGAGCCAAGGATCAC-3′ (in1) |
|
| 8F: 5′-CAAACCGGACCTCACAGCAG-3′ (ex4) |
GFAP: gDNA: 181 bp (GFAP variant c.719G>A detection assay) |
| 8R: 5′-CCCACCCTTATTCCCTGATTCTC-3′ (in4) |
|